Systemic administration of sialorphin attenuates experimental colitis in mice via interaction with mu and kappa opioid receptors

Maciej Sałaga , Anna Mokrowiecka , D. Jacenik , A. Cygankiewicz , Ewa Małecka-Panas , Radzisław Kordek , W. Krajewska , Małgorzata Sobocińska , Elżbieta Kamysz , Jakub Fichna

Abstract

n/a
Author Maciej Sałaga
Maciej Sałaga,,
-
, Anna Mokrowiecka
Anna Mokrowiecka,,
-
, D. Jacenik
D. Jacenik,,
-
, A. Cygankiewicz
A. Cygankiewicz,,
-
, Ewa Małecka-Panas
Ewa Małecka-Panas,,
-
, Radzisław Kordek
Radzisław Kordek,,
-
, W. Krajewska
W. Krajewska,,
-
, Małgorzata Sobocińska PChMB
Małgorzata Sobocińska,,
- Laboratory of Chemistry of Biological Macromolecules
, Elżbieta Kamysz PChMB
Elżbieta Kamysz,,
- Laboratory of Chemistry of Biological Macromolecules
, Jakub Fichna
Jakub Fichna,,
-
Other language title versions
Journal seriesJournal of Crohns & Colitis, ISSN 1873-9946
Issue year2017
Vol11
No8
Pages988-998
Publication size in sheets0.5
Keywords in Englishinflammatory bowel diseases, sialorphin, aminopeptidase N
DOIDOI:10.1093/ecco-jcc/jjx043
Languageen angielski
Score (nominal)40
ScoreMinisterial score = 40.0, 20-12-2017, ArticleFromJournal
Ministerial score (2013-2016) = 40.0, 20-12-2017, ArticleFromJournal
Publication indicators WoS Impact Factor: 2016 = 5.813 (2) - 2016=5.926 (5)
Citation count*0
Cite
Share Share

Get link to the record
msginfo.png


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back